Digital Health News | pharmaphorum

News

Takeda signs $1.7bn AI alliance with Iambic

Iambic bags another pharma partner, Takeda, which plans to use its AI platform to find drugs for cancer, gastrointestinal, and inflammatory disorders.

News

Black and white image of a white flag of surrender

Novo Nordisk rises as Hims & Hers backs down on oral GLP-1

Novo Nordisk's battered stock enjoyed a reprieve after Hims & Hers abandoned plans to launch a compounded version of the new Wegovy pill.

News

White House's TrumpRx platform has arrived

The Trump administration's long-promised direct-to-consumer (DTC) sales channel for medicines, TrumpRx, has finally gone live.

News

Hims & Hers copies Novo Nordisk's new Wegovy pill

Competition has already arrived for Novo Nordisk's Wegovy pill, as telehealth company Hims & Hers launches a compounded version.

News

Abbott's wireless heart failure sensor cleared for NHS use

A wireless sensor the size of a paperclip, Abbott's CardioMEMS HF, can now be used routinely by the NHS to monitor patients with heart failure.

News

Digital musculoskeletal care firm Sword buys rival Kaia

US digital physical therapy specialist Sword Health has bought its competitor Kaia Health for $285 million, positioning it for expansion in Europe.

Takeda signs $1.7bn AI alliance with Iambic

Novo Nordisk rises as Hims & Hers backs down on oral GLP-1

White House's TrumpRx platform has arrived

Hims & Hers copies Novo Nordisk's new Wegovy pill

Abbott's wireless heart failure sensor cleared for NHS use

Digital musculoskeletal care firm Sword buys rival Kaia

NHS to offer Wegovy to a million more people in England

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks